Ascendis crosses FDA finish line with once-weekly growth hormone—but Pfizer is hot on its trail

Ascendis crosses FDA finish line with once-weekly growth hormone—but Pfizer is hot on its trail
fkansteiner
Wed, 08/25/2021 – 19:09